Partnerships

An Inspiring New Patent Wall Recognizing Meaningful Contributions

The Frederick National Laboratory for Cancer Research has a new installation: a wall featuring 34 plaques highlighting patents granted to FNL researchers in recognition of their inventions and the breakthrough work being done at the laboratory. The “Innovations in Research” wall represents the mission of FNL staff to address some of the most urgent challenges in the biomedical sciences.

2023 Technology Showcase Highlights How Partnerships Benefit Patients

With 100 online attendees, 180 in-person participants, 15 posters, 16 technologies, and 45 speakers, the 2023 Technology Showcase offered a whirlwind look into biotechnology innovation happening at the Frederick National Laboratory for Cancer Research and National Cancer Institute.

NCI and FNL Technology Showcase Returns September 6

The National Cancer Institute and Frederick National Laboratory for Cancer Research will host the Technology Showcase on Wednesday, September 6, at the FNL’s Advanced Technology Research Facility in Frederick, Md. The seventh annual event highlights NCI and FNL inventions and capabilities available to the external healthcare and biotech communities and offers the opportunity for networking with others in the biomedical research field.  

In FNL-Backed Partnership, Students FLEX Their Skills and Feds Benefit

A new drug and vaccine delivery method that utilizes synthetic bacterial nanoparticles could improve chemotherapy treatments, and a groundbreaking alternative to drilled wells may soon be breaking ground in agricultural areas. The Federal Laboratory Education Accelerator and the work of Master of Business Administration students across the country are helping move these and other far-ranging technologies out of the laboratory and into the market.

FNL Celebrates Year One of Historically Black Colleges & Universities Initiative

Frederick National Laboratory’s Academic Summer Trainees Program provides graduate and undergraduate students with the chance to work with and learn from some of the nation’s leading scientists. The program now includes students from several Historically Black Colleges and Universities (HBCUs) and offers them increased access to advanced research and training, along with experience in biomedical programs, cancer research, and state-of-the-art technologies at FNL.

Collective Planning Effort Enables Hybrid Technology Showcase Success

In September, around 300 attendees participated in the sixth annual Technology Showcase, a unique event that brings together entrepreneurs, pharmaceutical and biotechnology industry representatives, development organizations, and scientists. Some attended from their laptops while others donned their business suits and enjoyed Caribbean-style food as they networked and listened to the presentations in person at the Frederick National Laboratory’s Advanced Technology Research Facility.

Annual Technology Showcase to Spotlight Collaboration Opportunities with NCI and FNL

The National Cancer Institute and Frederick National Laboratory for Cancer Research will hold the annual Technology Showcase on Wednesday, Sept. 7 in a hybrid format to welcome in-person attendees as well as remote participants from around the United States and the world. The event is scheduled from noon to 5:30 pm ET at the FNL’s Advanced Technology Research Facility in Frederick, Md.

Technology Transfer Managers Are Here to Make Agreements and Patents Painless

NCI and Frederick National Laboratory investigators make important scientific discoveries every day. Sometimes those discoveries lead to an invention. While competitive science can make it tempting to report the findings right away, that might not be the best idea. Instead, it’s time to talk with a technology transfer manager.

2021 Technology Showcase Returns with a New Focus on the Patient’s Voice

Block off the afternoon of September 1, 2021, in your calendar because the Technology Showcase is returning for its fifth year. The event will be fully virtual and, as always, feature exciting biomedical technologies, panels on important topics for industry stakeholders, and various poster pitches. New this year is an increased focus on the patient’s voice.